ligand.com (LGND): Net earnings per share growth forecast for next year

Ligand Pharmaceuticals (LGND) - corporate logo

Ligand Pharmaceuticals (LGND) employs a strategy based on the aggressive acquisition of royalties and intellectual property rights. Revised earnings per share (EPS) targets confirm the effectiveness of this model, where the value of 24.30 characterizes this level. Success is driven by the company's status as a reliable partner for global laboratories and the recognition of its unique molecule solubility enhancement methods, which render many drugs viable.

Ligand Pharmaceuticals Incorporated (LGND): Net earnings per share growth forecast for next year from 07/04/2022 to 11/17/2026

Summary analytical data breakdowns for Ligand (LGND)

Basic company analysis:LGND, Ligand
Finished products of ligand.com

To objectively assess the issuer's value, it is critical for the manager to understand the extent to which the current price is justified by future earnings, which is measured via the consensus earnings per share (EPS) forecast. By analyzing the EPS forecast chart, the investor tracks market expectations for net income, where stable royalties and intellectual property protection under strict FDA oversight serve as the key growth drivers for Ligand Pharmaceuticals (LGND).

Competing companies

Net earnings per share growth forecast for next year Haleon plc|Expected net earnings per share growth next year kenvue.com KVUE|Net earnings per share growth forecast for next year Verona Pharma (VRNA)|MENS (Jyong Biotech Limited) - Expected earnings per share trend next year|Earnings growth forecast for next year AMRX (Amneal Pharmaceuticals, Inc.)|PRGO (Perrigo Company) - Net earnings per share change forecast for next year|ALVO - Net earnings per share growth forecast for next year|Consensus forecast of earnings per share growth for next year liquidia.com LQDA|Galapagos (GLPG) - Net earnings per share growth forecast for next year|ANIP - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year MannKind Corporation|AMPH: Expected earnings per share trend next year|Net earnings per share growth forecast for next year Pacira BioSciences (PCRX)|SPRY: Net earnings per share change forecast for next year|Theravance Biopharma, Inc. - Expected earnings per share growth for next year|Projected earnings per share increase next year AQST (Aquestive Therapeutics, Inc.)|SCPH - Net earnings per share growth forecast for next year|Consensus forecast of earnings per share growth for next year tectonictx.com TECX|TNXP: Earnings growth forecast for next year|Projected earnings per share growth rate for next year SXTC|Expected earnings per share growth for next year EPRX|BioHarvest (BHST) - Consensus forecast of earnings per share growth for next year|Earnings growth forecast for next year EXOZ|Earnings growth forecast for next year Oramed (ORMP)|Entera Bio Ltd. - Expected earnings per share growth for next year|ipatherapeutics.com (HYFT) - Expected net earnings per share growth next year|ABVC - Net earnings per share growth forecast for next year|Net earnings per share change forecast for next year CPIX|QNTM: Earnings growth forecast for next year|FGEN - Consensus forecast of earnings per share growth for next year|TELO (Telomir Pharmaceuticals Corp) - Earnings growth forecast for next year|RANI (Rani Therapeutics) - Projected earnings per share increase next year|Net earnings per share growth forecast for next year Synergy CHC Corp. (SNYR)|RLYB (Rallybio) - Expected earnings per share trend next year|Net earnings per share growth forecast for next year lexariabioscience.com LEXX|Earnings growth forecast for next year Pulmatrix Corporation PULM|PTHL - Net earnings per share growth forecast for next year|Consensus forecast of earnings per share growth for next year Aptorum Group Ltd APM|LYRA (Lyra Therapeutics) - Expected earnings per share growth for next year|IBO - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year TNF Pharmaceuticals, Inc.|Expected earnings per share growth for next year cbdMD, Inc. (YCBD)|Net earnings per share growth forecast for next year PainReform Limited (PRFX)|Expected earnings per share growth for next year Altamira Therapeutics Ltd CYTO|Earnings growth forecast for next year LIPO (lipella.com)|Expected earnings per share trend next year OPTN|PIRS - Net earnings per share growth forecast for next year|Procaps Group Corp (PROC) - Expected earnings per share growth for next year|Petros (PTPI) - Net earnings per share growth forecast for next year|Net earnings per share change forecast for next year QLI (Qilian International)|Expected earnings per share growth for next year SLRN|TFF Pharmaceuticals, Inc. - Net earnings per share change forecast for next year